|
1
|
Ridge CA, Pua BB and Madoff DC:
Epidemiology and staging of renal cell carcinoma. Semin Intervent
Radiol. 31:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
3
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iwamoto H, Kanda Y, Sejima T, Osaki M,
Okada F and Takenaka A: Serum miR-210 as a potential biomarker of
early clear cell renal cell carcinoma. Int J Oncol. 44:53–58.
2014.
|
|
5
|
Ljungberg B, Cowan NC, Hanbury DC, Hora M,
Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF and Sinescu IC;
European Association of Urology Guideline Group: EAU guidelines on
renal cell carcinoma: The 2010 update. Eur Urol. 58:398–406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Linehan WM, Srinivasan R and Schmidt LS:
The genetic basis of kidney cancer: A metabolic disease. Nat Rev
Urol. 7:277–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fendler A, Stephan C, Yousef GM and Jung
K: MicroRNAs as regulators of signal transduction in urological
tumors. Clin Chem. 57:954–968. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oulas A, Karathanasis N, Louloupi A and
Poirazi P: Finding cancer-associated miRNAs: Methods and tools. Mol
Biotechnol. 49:97–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maher ER: Genomics and epigenomics of
renal cell carcinoma. Semin Cancer Biol. 23:10–17. 2013. View Article : Google Scholar
|
|
10
|
Rydzanicz M, Wrzesiński T, Bluyssen HA and
Wesoly J: Genomics and epigenomics of clear cell renal cell
carcinoma: Recent developments and potential applications. Cancer
Lett. 341:111–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chow TF, Youssef YM, Lianidou E, Romaschin
AD, Honey RJ, Stewart R, Pace KT and Yousef GM: Differential
expression profiling of microRNAs and their potential involvement
in renal cell carcinoma pathogenesis. Clin Biochem. 43:150–158.
2010. View Article : Google Scholar
|
|
12
|
Wulfken LM, Moritz R, Ohlmann C,
Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel
G, von Ruecker A, Müller SC and Ellinger J: MicroRNAs in renal cell
carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS
One. 6:e257872011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Muller S and Nowak K: Exploring the
miRNA-mRNA regulatory network in clear cell renal cell carcinomas
by next-generation sequencing expression profiles. Biomed Res Int.
2014:9484082014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Slaby O, Jancovicova J, Lakomy R, Svoboda
M, Poprach A, Fabian P, Kren L, Michalek J and Vyzula R: Expression
of miRNA-106b in conventional renal cell carcinoma is a potential
marker for prediction of early metastasis after nephrectomy. J Exp
Clin Cancer Res. 29:1756–9966. 2010. View Article : Google Scholar
|
|
15
|
Hui AB, Lenarduzzi M, Krushel T, Waldron
L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B,
Waldron J, et al: Comprehensive MicroRNA profiling for head and
neck squamous cell carcinomas. Clin Cancer Res. 16:1129–1139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ji T, Zheng ZG, Wang FM, Xu LJ, Li LF,
Cheng QH, Guo JF and Ding XF: Differential microRNA expression by
Solexa sequencing in the sera of ovarian cancer patients. Asian Pac
J Cancer Prev. 15:1739–1743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni
L, Zhang WG, Nan KJ, Song TS and Huang C: MicroRNA profiling of
human gastric cancer. Mol Med Rep. 2:963–970. 2009.PubMed/NCBI
|
|
20
|
Yu X, Wu Y, Liu Y, Deng H, Shen Z, Xiao B
and Guo J: miR-21, miR-106b and miR-375 as novel potential
biomarkers for laryngeal squamous cell carcinoma. Curr Pharm
Biotechnol. 15:503–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Zhang H, Zhang A, Han L, Wang K,
Liu R, Yang S, Pu P, Shen C, Kang C and Yu C: Upregulation of
miR-20a and miR-106b is involved in the acquisition of malignancy
of pediatric brainstem gliomas. Oncol Rep. 28:1293–1300.
2012.PubMed/NCBI
|
|
22
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; New York, NY: pp. 479–489. 2010
|
|
23
|
Schaefer A, Stephan C, Busch J, Yousef GM
and Jung K: Diagnostic, prognostic and therapeutic implications of
microRNAs in urologic tumors. Nat Rev Urol. 7:286–297. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Prasad R and Katiyar SK: Down-regulation
of miRNA-106b inhibits growth of melanoma cells by promoting
G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1
protein. Oncotarget. 5:10636–10649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu F, Gong J, Huang W, Wang Z, Wang M,
Yang J, Wu C, Wu Z and Han B: MicroRNA-106b-5p boosts glioma
tumorigenesis by targeting multiple tumor suppressor genes.
Oncogene. 33:4813–4822. 2014. View Article : Google Scholar
|
|
26
|
Hudson RS, Yi M, Esposito D, Glynn SA,
Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH,
et al: MicroRNA-106b-25 cluster expression is associated with early
disease recurrence and targets caspase-7 and focal adhesion in
human prostate cancer. Oncogene. 32:4139–4147. 2013. View Article : Google Scholar
|
|
27
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong P, Kaneuchi M, Watari H, Sudo S and
Sakuragi N: MicroRNA-106b modulates epithelial-mesenchymal
transition by targeting TWIST1 in invasive endometrial cancer cell
lines. Mol Carcinog. 53:349–359. 2014. View
Article : Google Scholar
|
|
29
|
Xu Y, Wang K, Gao W, Zhang C, Huang F, Wen
S and Wang B: MicroRNA-106b regulates the tumor suppressor RUNX3 in
laryngeal carcinoma cells. FEBS Lett. 587:3166–3174. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cai K, Wang Y and Bao X: MiR-106b promotes
cell proliferation via targeting RB in laryngeal carcinoma. J Exp
Clin Cancer Res. 30:1756–9966. 2011. View Article : Google Scholar
|
|
31
|
Rubin H: Contact interactions between
cells that suppress neoplastic development: Can they also explain
metastatic dormancy? Adv Cancer Res. 100:159–202. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang TS, Yang XH, Chen X, Wang XD, Hua J,
Zhou DL, Zhou B and Song ZS: MicroRNA-106b in cancer-associated
fibroblasts from gastric cancer promotes cell migration and
invasion by targeting PTEN. FEBS Lett. 588:2162–2169. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meenhuis A, van Veelen PA, de Looper H,
van Boxtel N, van den Berge IJ, Sun SM, Taskesen E, Stern P, de Ru
AH, van Adrichem AJ, et al: MiR-17/20/93/106 promote hematopoietic
cell expansion by targeting sequestosome 1-regulated pathways in
mice. Blood. 118:916–925. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shen G, Jia H, Tai Q, Li Y and Chen D:
miR-106b downregulates adenomatous polyposis coli and promotes cell
proliferation in human hepatocellular carcinoma. Carcinogenesis.
34:211–219. 2013. View Article : Google Scholar
|
|
35
|
Yau WL, Lam CS, Ng L, Chow AK, Chan ST,
Chan JY, Wo JY, Ng KT, Man K, Poon RT and Pang RW: Over-expression
of miR-106b promotes cell migration and metastasis in
hepatocellular carcinoma by activating epithelial-mesenchymal
transition process. PLoS One. 8:e578822013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Tan W, Neo TW, Aung MO, Wasser S,
Lim SG and Tan TM: Role of the miR-106b-25 microRNA cluster in
hepatocellular carcinoma. Cancer Sci. 100:1234–1242. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang R, Wang W, Li F, Zhang H and Liu J:
MicroRNA-106b~25 expressions in tumor tissues and plasma of
patients with gastric cancers. Med Oncol. 31:2432014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cai H, Yuan Y, Hao YF, Guo TK, Wei X and
Zhang YM: Plasma microRNAs serve as novel potential biomarkers for
early detection of gastric cancer. Med Oncol. 30:4522013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou X, Zhang X, Yang Y, Li Z, Du L, Dong
Z, Qu A, Jiang X, Li P and Wang C: Urinary cell-free microRNA-106b
as a novel biomarker for detection of bladder cancer. Med Oncol.
31:1972014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Arabi L, Gsponer JR, Smida J, Nathrath M,
Perrina V, Jundt G, Ruiz C, Quagliata L and Baumhoer D:
Upregulation of the miR-17–92 cluster and its two paraloga in
osteosarcoma - reasons and consequences. In: Genes Cancer. 5. pp.
56–63. 2014
|
